NDC 51672-4044-01 - Clorazepate Dipotassium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-4044
- Requested NDC
- 51672-4044-01
- Package NDCs from labels
- 51672-4044-1, 51672-4044-2, 51672-4044-3, 51672-4044-01
- Manufacturer
- PD-Rx Pharmaceuticals, Inc.
- Effective date
- 2026-09-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Clorazepate Dipotassium Tablets USP 15 mg | PD-Rx Pharmaceuticals, Inc. | 2026-09-14 | HUMAN PRESCRIPTION DRUG LABEL |
| Clorazepate Dipotassium - Clinical Solutions Wholesale, LLC | Clinical Solutions Wholesale, LLC | 2026-07-24 | HUMAN PRESCRIPTION DRUG LABEL |
| Clorazepate Dipotassium Tablets USP, 3.75 mg, 7.5 mg, & 15 mg | Sun Pharmaceutical Industries, Inc. | Taro Pharmaceutical Industries, Ltd. | 2026-07-14 | HUMAN PRESCRIPTION DRUG LABEL |
| Clorazepate Dipotassium - Coupler LLC | Coupler LLC | 2025-01-28 | HUMAN PRESCRIPTION DRUG LABEL |
| Clorazepate Dipotassium Tablets USP, 15 mg | PD-Rx Pharmaceuticals, Inc. | 2025-01-09 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-4044-1 | Clorazepate Dipotassium | 100 in 1 BOTTLE | TABLET | 100 | 7 | |
| 51672-4044-2 | Clorazepate Dipotassium | 500 in 1 BOTTLE | TABLET | 500 | 7 | |
| 51672-4044-3 | Clorazepate Dipotassium | 1000 in 1 BOTTLE | TABLET | 1000 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-4044 | CLORAZEPATE DIPOTASSIUM TABLET [TARO PHARMACEUTICALS U.S.A., INC.] | 7 | Current NDC, Legacy NDC, 3 package rows | 20240926_499a6989-8912-44b7-b1eb-ee8f85ae378f.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51672-4044-1 | EA - Each | 51672-4044 | 2dca8912-9c73-4790-a352-6b367bfb3b20 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| LACTATED RINGERS AND DEXTROSE | SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, AND DEXTROSE MONOHYDRATE | HF Acquisition Co LLC, DBA HealthFirst | a62cf623-9b8a-37e0-e053-2995a90add5b | 2020-05-21 | Warnings, Adverse reactions | 660YQ98I10 |
| BronCare | ECHINACEA, LAPPA, RUMEX CRISP., ANTIMON. TART., ARSENICUM ALB., BRYONIA, CAMPHORA, CHELIDONIUM MAJ., CINCHONA, DROSERA, EUCALYPTUS, HEPAR SULPH. CALC., HISTAMINUM HYDROCHLORICUM, IPECAC., KALI BIC., KALI CARB., KALI IOD., LYCOPODIUM, MYRRHA, NAT. SULPHURICUM, NUX VOM., PHOS., PULSATILLA, SAINGUINARIA, SPONGIA, STANNUM MET., TUSSILAGO FAR., VERBASCUM, INFLUENZINUM | Newton Laboratories, Inc. | a5281807-675f-07f7-e053-2995a90a3a8a | 2020-05-18 | Warnings | BQN1B9B9HA |
| Isolyte S | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE | B. Braun Medical Inc. | 7e8fe27f-ff82-48c1-9bf6-3c589c8e985d | 2020-05-14 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Genus Lifesciences Inc. | 23d818e7-c076-40de-8dc1-0b51ba4be96a | 2020-04-28 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Lupin Pharmaceuticals,Inc. | 1bbacdbb-91fa-4897-a00c-1b293de27b83 | 2020-04-27 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Mylan Pharmaceuticals Inc. | c64ed4c0-1e27-42b3-9625-fb4e0d31e271 | 2020-04-15 | Warnings, Adverse reactions | 660YQ98I10 |
| Dextrose and Electrolyte No. 48 | SODIUM LACTATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, MONOBASIC POTASSIUM PHOSPHATE, SODIUM CHLORIDE AND DEXTROSE MONOHYDRATE | Baxter Healthcare Company | b283a454-0c20-4fbf-92d3-dae1f3cd3cad | 2020-02-13 | Warnings, Adverse reactions | 660YQ98I10 |
| Plasma-Lyte A | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE AND MAGNESIUM CHLORIDE | Baxter Healthcare Corporation | 6ec9e61c-2c26-402f-8604-f446b2e34058 | 2019-08-05 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride in Dextrose | POTASSIUM CHLORIDE AND DEXTROSE MONOHYDRATE | Baxter Healthcare Company | 45de5402-5e61-4bbd-8bbc-5e3392c9920e | 2019-07-15 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | BluePoint Laboratories | 431ff2ef-567c-4b60-af43-f4da61febaad | 2019-07-03 | Warnings, Adverse reactions | 660YQ98I10 |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE EXTENDED-RELEASE | Solco Healthcare LLC | f704b746-ab75-4484-8704-5baa94a07750 | 2019-04-30 | Warnings, Adverse reactions | 660YQ98I10 |
| Tinnitus Relief | CINCHONA OFFICINALIS BARK,SALICYLIC ACID,QUININE SULFATE,FERRUM PHOSPHORICUM,POTASSIUM CHLORIDE,CALOMEL,ALLYLTHIOUREA,. | Homeocare Laboratories | 30d67273-b9ec-4f3e-ace6-87a68325aaf1 | 2019-02-28 | Warnings | 660YQ98I10 |
| Potassium Chloride in Dextrose and Sodium Chloride | POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE AND SODIUM CHLORIDE | Baxter Healthcare Company | c553fed1-3de5-4826-8eff-633b5923bf0b | 2019-02-21 | Warnings, Adverse reactions | 660YQ98I10 |
| Magnesium Oxide 400mg | MAGNESIUM OXIDE 400MG | Allegiant Health | 2ea68874-8c20-4284-bd0a-f07768057b83 | 2019-01-28 | Warnings | 3A3U0GI71G |
| Potassium Chloride in Sodium Chloride | POTASSIUM CHLORIDE AND SODIUM CHLORIDE | Baxter Healthcare Company | becc7410-0a25-49f5-b0c3-240078479dc8 | 2019-01-11 | Warnings, Adverse reactions | 660YQ98I10 |
| Skin Klear Acne Relief | TRIBASIC CALCIUM PHOSPHATE, FUMARIA OFFICINALIS FLOWERING TOP, ARCTIUM LAPPA ROOT, SODIUM CHLORIDE, SAPONARIA OFFICINALIS ROOT, SILICON DIOXIDE, SOLIDAGO VIRGAUREA FLOWERING TOP, SULFUR, VIOLA TRICOLOR | Homeocare Laboratories | 65afbc20-611b-4bc4-a151-c633bec66a82 | 2018-12-31 | Warnings | ETJ7Z6XBU4 |
| Sinus Relief | ASAFETIDA, ECHINACEA ANGUSTIFOLIA, CALCIUM SULFIDE, POTASSIUM DICHROMATE, LUFFA OPERCULATA WHOLE, SILICON DIOXIDE, SINUSITISINUM | Homeocare Laboratories | 84483171-df92-47de-9203-ed02d64fb5fb | 2018-12-31 | Warnings | ETJ7Z6XBU4 |
| Hair-X Hair Loss Relief | CADMIUM SULFATE, GRAPHITE, PHOSPHORIC ACID, SILICON DIOXIDE, SELENIUM, THALLIUM, USTILAGO MAYDIS | Homeocare Laboratories | 00b62179-e03b-4972-902d-3a0c969b59bc | 2018-12-31 | Warnings | ETJ7Z6XBU4 |
| GUNA-SINUS NOSE | ALTHAEA OFFICINALIS LEAF - ASCORBIC ACID - BLACK CURRANT - CALCIUM SULFIDE - COPPER - ECHINACEA ANGUSTIFOLIA - GOLDENSEAL - LACHESIS MUTA VENOM - LOBARIA PULMONARIA - MANGANESE - MERCURIC SULFIDE - ONION - PLANTAGO MAJOR - POTASSIUM CARBONATE - PULSATILLA VULGARIS - SILICON DIOXIDE - SILVER NITRATE - SINUSITISINUM - SUS SCROFA NASAL MUCOSA - SUS SCROFA THYMUS - SUS SCROFA URINARY BLADDER - | Guna spa | 36fef678-17c6-4d2a-a0f0-ddb298611f25 | 2018-12-22 | Warnings | ETJ7Z6XBU4 |
| Gastrozen | COFFEA TOSTA, GLYCYRRHIZA, PHYTOLACCA, TARAXACUM, HYDRASTIS, ARSENICUM ALB, GELSEMIUM, MERC SOLUB, NITRICUM AC, NUX VOM, PETROLEUM, PHOSPHORICUM AC, PHOSPHORUS, BROMIUM, CADMIUM SULPHURICUM, CINCHONA, CONIUM, HYDROGEN, IODIUM, LACHESIS, PULSATILLA, SILICEA, SULPHURICUM AC | Natural Creations, Inc | 98dd756f-6774-47c3-bdfb-deff82fb801d | 2018-12-21 | Warnings | ETJ7Z6XBU4 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.